Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids
- PMID: 3669005
- DOI: 10.1021/jm00394a007
Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids
Abstract
Five (2,2-dimethylchroman-6-yl)alkanoic acids were synthesized and tested for antigelling activities. It was envisioned that these agents might bind via hydrophobic bonding to nonpolar sites of the "donor-acceptor" regions of hemoglobin S. Several (2,2-dimethylchroman-6-yl)alkanoic acids containing 1-4 carbon atoms on the side-chain residue were designed to interact at the acceptor site, were synthesized, and were found to be moderately potent antigelling agents. The weak activity observed for two of the acids at low concentrations is rationalized in terms of weak binding affinities or multiple binding to active and nonactive sites. The effect of these compounds on shifting the allosteric equilibrium was small or negligible. The low toxicity of one of the (2,2-dimethylchroman-6-yl)alkanoic acids demonstrates the potential use of yet another class of compounds that can be modified in the development of antisickling agents.
Similar articles
-
Design, synthesis, and testing of potential antisickling agents. 5. Disubstituted benzoic acids designed for the donor site and proline salicylates designed for the acceptor site.J Med Chem. 1984 Dec;27(12):1549-59. doi: 10.1021/jm00378a005. J Med Chem. 1984. PMID: 6094807
-
Design, synthesis, and testing of potential antisickling agents. 1. Halogenated benzyloxy and phenoxy acids.J Med Chem. 1982 Sep;25(9):1015-7. doi: 10.1021/jm00351a002. J Med Chem. 1982. PMID: 7131479 No abstract available.
-
Design, synthesis, and testing of potential antisickling agents. 9. Cyclic tetrapeptide homologs as mimics of the mutation site of hemoglobin S.Int J Pept Protein Res. 1987 Apr;29(4):509-20. doi: 10.1111/j.1399-3011.1987.tb02278.x. Int J Pept Protein Res. 1987. PMID: 3596902
-
Design, synthesis, and testing of antisickling agents. 2. Proline derivatives designed for the donor site.J Med Chem. 1983 Apr;26(4):549-54. doi: 10.1021/jm00358a017. J Med Chem. 1983. PMID: 6834388
-
Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.Boll Chim Farm. 2000 Mar-Apr;139(2):73-80. Boll Chim Farm. 2000. PMID: 10920532
Cited by
-
X-ray crystallography and sickle cell disease drug discovery-a tribute to Donald Abraham.Front Mol Biosci. 2023 May 24;10:1136970. doi: 10.3389/fmolb.2023.1136970. eCollection 2023. Front Mol Biosci. 2023. PMID: 37293554 Free PMC article. Review.
-
Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry.SLAS Discov. 2023 Sep;28(6):255-269. doi: 10.1016/j.slasd.2023.02.006. Epub 2023 Feb 28. SLAS Discov. 2023. PMID: 36863508 Free PMC article. Review.
-
Privileged substructures for anti-sickling activity via cheminformatic analysis.RSC Adv. 2018 Feb 7;8(11):5920-5935. doi: 10.1039/c7ra12079f. eCollection 2018 Feb 2. RSC Adv. 2018. PMID: 35539618 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources